Jacqueline Tamis-Holland, MD Email Jacqueline Tamis-Holland
-
- Position
- ASSOCIATE PROFESSOR | Medicine, Cardiology
-
- Specialties
- Cardiovascular Disease
- Interventional Cardiology
-
- Language
- English
-
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai St. Luke's and Mount Sinai West
-
- Phone
- New Office 212-492-5550212-492-5550
- New Office 212-280-3101212-280-3101
Dr. Jacqueline E. Tamis-Holland is an interventional cardiologist at Mount Sinai St. Luke’s and Mount Sinai West Hospitals. She is the Associate Director for the Mount Sinai St. Luke’s Cardiac Cath Labs as well as Program Director for the Interventional Cardiology Fellowship. In addition, she serves as the Director of Women’s Heart NY, a multi-site comprehensive program designed for women who are at risk for or have a history of heart disease.
Dr Tamis-Holland is a spokesperson for the American Heart Association, and is on the writing committee for the American Heart Association/American College of Cardiology’s “Guidelines for ST Segment elevation Infarction”. She is also an executive committee member for the American Heart Association’s Mission Lifeline Program and a member of the medical leadership committee of the NYC Go Red for Women campaign. Dr Tamis-Holland serves on the American College of Cardiology’s Council for Academic Cardiology and Interventional Cardiology. She was recently rewarded a community out-reach grant from the American Heart Association to develop a family nutritional educational program for spanish speaking patients.
Dr Tamis-Holland holds a post as Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai. She has lectured extensively on topics related to coronary artery disease at local and national cardiology meetings. Dr Tamis-Holland was voted teacher of the year by the Cardiology Fellows at Mount Sinai West.
Dr. Tamis-Holland is also a skilled medical researcher. She has published numerous peer-reviewed articles and book chapters. She is a reviewer for the New England Journal of Medicine, the Journal of the American College of Cardiology and the American Heart Journal.
Certification
Interventional Cardiology
Clinical Focus
- Acute Coronary Syndrome
- Angiography
- Cardiac Catherization
- Cardiomyopathy
- Cardiovascular Disease
- Coronary Angioplasty
- Heart Attack/Acute Coronary Syndrome
- Valvular Heart Disease
Education
MD, New York University School of Medicine
Residency, Internal Medicine
Bellevue Hospital Center
Fellowship, Cardiology
Mount Sinai St. Luke's
Fellowship, Interventional Cardiology
Mount Sinai St. Luke's
Language
English
Download the CV
2014
American Heart Association, Heart of Our Mission Volunteer Award
2014
Luminary of the Heart, American Heart Association, Go Red for Women NYC
Her research interests include acute coronary syndromes, and women and heart disease.
Nichols K, Tamis JE, DePuey EG, Mieres J, Malhotra S, and Rozanski A. Relationship of Gated SPECT Ventricular Function Parameters to Angiographic Measurements. J Nucl Cardiol 5:295-303, 1998.;.
Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, Topol EJ, Califf RM. Sex, Clinical Presentation, and Outcome in Patients With Acute Coronary Syndromes. Global use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIB Investigators. N Engl J Med Jul 22;341(4):226-32, 1999.;.
Tamis JE, Steinberg JS. Atrial Fibrillation Independently Prolongs Hospital Stay after Coronary Artery Bypass Surgery. Clinic Cardiol 23:155-159, 2000.;.
Tamis-Holland JE, Homel P, Durani M, Iqbal, Sutandar A, Mindich BP, Steinberg JS. Atrial Fibrillation After Minimally Invasive Direct Coronary Artery Bypass. J Am Coll Cardiol 36: 1884-1888, 2000.;.
Balcetyte-Harris N, Tamis JE, Homel P, Menchavez E, and Steinberg JS. Randomized Study of Early Intravenous Esmolol versus Oral Beta-Blockers in Preventing Post-CABG Atrial Fibrillation in High Risk Patients Identified by the Signal-Averaged ECG: Results of a Pilot Study. A. N. E. 7:86-91, 2002..;.
Maniar PB, Balcetyte-Harris N, Tamis JE, and Steinberg JS. Intravenous versus oral beta-blockers for prevention of post-CABG atrial fibrillation in high-risk patients identified by signal-averaged ECG: lessons of a pilot study. Card Electrophysiol Rev 2003;7:158-61.;.
Tamis-Holland JE, Palazzo A, Stebbins AL, Slater JN, Boland J, Ellis SG, and Hochman JS. Benefits of Direct Angioplasty for Women and Men with Acute Myocardial Infarction: Results of the GUSTO II-B PTCA Substudy. Am Heart J; 147:133-129, 2004.;.
Tamis-Holland JE, Kowalski M, Rill V, Firoozi K, and Steinberg JS. Patterns of Atrial Fibrillation After Cardiac Surgery: Impact on Length of Stay. A. N. E. 11;139-44, 2006 .;.
Syed T, Tamis-Holland J, Coven D, Hong MK, Can Glycopyrrolate Replace Temporary Pacemaker and Atropine. J Inv Cardiol 2008;20:19A–21A.;.
Bangalore S, Messerli, FH, Ou FS, Tamis-Holland J, Palazzo A, Roe, MT, Hong, MH, Peterson ED, for the CRUSADE Investigators. Blood Pressure Paradox in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: Results From 139,194 Patients in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) Quality Improvement Initiative. Am Heart J 2009;157(3):525-531..;.
Bangalore S, Messerli, FH, Ou FS, Tamis-Holland J, Palazzo A, Roe, MT, Hong, MH, Peterson ED, for the CRUSADE Investigators. The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative. European Heart Journal, 2009: DOI 10.1093/eurheart/ehp 397..;.
Aziz EA, Pulimi S, Coleman C, Florita C, Musat D, Tormey D, Fawzy A, Lee S, Herzog, E, Coven DL, Tamis-Holland J, Hong MK. Increased vascular complications in patients with renal dysfunction undergoing percutaneous coronary procedures using arteriotomy closure devices. J Inv Cardiol 2010:22;8-13..;.
Tamis-Holland JE, Lu J, Bittner V, Magee MF, Lopes N, Adler DS, Kip KE, Schwartz L, Groenewoud YA, Jacobs AK, for the BARI 2D Study Group. Sex, Clinical Symptoms, and Angiographic Findings in Patients with Diabetes Mellitus and Coronary Artery Disease (From the Bypass Angioplasty Revascularization Investigation [BARI] 2D). Am J Cardiol 2011;107:980-5.;.
Reynolds HR, Forman SA, Tamis-Holland JE, Steg PG, Mark DB, Pearte CA, Carvalho AC, Sopko G, Liu L, Lamas GA, Kruk M, Loboz-Grudzien K, Ruzyllo W, Hochman JS Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT). Am Heart J. 2012 Mar;163(3):462-9.;.
O’Gara P, Kushner FG, Ascheim DD, Casey DE, Chung MK, DeLemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornator JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, and Zhao DX. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol. 2013;61:e78-e140 .;.
O’Gara P, Kushner FG, Ascheim DD, Casey DE, Chung MK, DeLemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornator JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, and Zhao DX. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Executive Summary. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol. 2013;61:485-510..;.
O’Gara P, Kushner FG, Ascheim DD, Casey DE, Chung MK, DeLemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornator JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, and Zhao DX. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Executive Summary. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation. 2013; 127: 529-555.;.
O’Gara P, Kushner FG, Ascheim DD, Casey DE, Chung MK, DeLemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornator JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, and Zhao DX. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation Circulation. 2013;127:e362-e425 .;.
O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovas Interv 2013;82e1-27. .;.
Tamis-Holland JE, Lu J, Korytkowski M, Magee M, Rogers WJ, Lopes N, Mighton L, Jacobs AK, for the BARI 2D Study Group Sex Differences in Presentation and Outcome Among Patients with Type 2 Diabetes and Coronary Artery Disease Treated With Contemporary Medical Therapy With or Without Prompt Revascularization: A Report From BARI 2D. J Am Coll Cardiol 2013;61:1767-76 .;.
Chorzempa A, Tamis J, Simon C, Palazzo A, Leber R, Coven D, and Hong MK. Safety and Feasibility of Intra-arterial Bivalirudin Bolus Administration During Primary Angioplasty. .;.
Benjo AM, El-Hayek GE, Messerli F, DiNicolantonio JJ, Hong MK, Aziz EF, Herzog E, and Tamis-Holland JE. High Dose Statin Loading Prior to Percutaneous Coronary Intervention Decreases Cardiovascular Events: A Meta-analysis of Randomized Controlled Trials. Catheter Cardiovasc Interv. 2015 Jan 1;85:53-60.;.
El-Hayek GE, Messeri F, Bangalore S, Hong M, Herzog E, Benjo AM and Tamis-Holland, JE. Meta-analysis of Randomized Clinical Trials Comparing Short term -vs- Long term Dual Antiplatelet Therapy Following Drug Eluting Stents. Am J Cardiol 2014; 114:236–242.;.
Krone RJ, Althouse AD, Tamis-Holland J, Venkitachalam L, Campos A, Forker Jacobs AK, Ocampo S, Steiner G, Fuentes F, Pena Sing IR, Mori Brooks M, for the BARI 2D Study Group. Appropriate Revascularization in Stable Angina, Lessons from the BARI 2D Trial. Can J Cardiol 2014;30:1595-1601..;.
Magee M, Tamis-Holland J, Lu J, Bittner V, Mori Brooks M, Lopes N, Jacobs AK. Sex, Prescribing Practices and Guideline Recommended, Blood Pressure and LDL Cholesterol Targets at Baseline in the BARI 2D Trial. Int J Endocrin 2015: Article ID 610239.;.
El-Hayek GE, Gershlick AH, Hong MK, Casso Dominguez A, Banning A, Afshar AE, Herzog E, Tamis-Holland JE. Meta-Analysis of Randomized Controlled Trials Comparing Multivessel Versus Culprit-Only Revascularization for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention. Am J Cardiol. 2015 Jun 1;115(11):1481-6. .;.
Bittl JA, Tamis-Holland JE, Lang CD, and He Y. Outcomes after multivessel or culprit-Vessel intervention for ST-elevation myocardial infarction in patients with multivessel coronary disease: A Bayesian cross-design meta-analysis. Catheter Cardiovasc Interv. 2015 May 22. doi: 10.1002/ccd.26025. [Epub ahead of print].;.
Rab T, Kern KB, Tamis-Holland JE, Henry TD, McDaniel M, Dickert NW, Cigarroa JE, Keadey M, Ramee S for the Interventional Council, American College of Cardiology. Cardiac Arrest: A Treatment Algorithm for Emergent Invasive Cardiac Procedures in the Resuscitated Comatose Patient. 2015 J Am Coll Card 2015;66:62-73.;.
Arad, AD, DiMenna FJ, Thomas N, Tamis-Holland J, Weil R, Geliebter A and Albu JB. Effect of high-intensity interval training on metabolic flexibility and insulin sensitivity in obese non-diabetic African-American women. J Appl Physiol 2015doi: 10.1152/japplphysiol.00306.2015. [Epub ahead of print].;.
Bavishi C, Bangalore S, Patel D, Chatterjee S, Trivedi V, Tamis-Holland JE. Short and long-term mortality in women and men undergoing primary angioplasty: A comprehensive meta-analysis. Int J Cardiol 2015;198:123–130.;.
Bavishi C, Koulova A, Bangalore S, Sawant A, Chatterjee S, Ather S, Valencia J, Sarafoff N, Rubboli A, Airaksinen JK, Lip GYH, and Tamis-Holland JE. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies Catheter Cardiovasc Interv. 2015 DOI: 10.1002/ccd.26234. [Epub ahead of print].;.
Casso Dominguez A, Bittl JA, El-Hayek G, Contreras E, Tamis-Holland, JE. Meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST-segment elevation myocardial infarction. Catheter Cardiovasc Interv. 2015. DOI: 10.1002/ccd.26352. [Epub ahead of print].;.
Levine GN, O’Gara PT, Bates ER, Blankenship JC, Kushner FG, Ascheim DD, Bailey SR, Bittl JA, Brindis RG, Casey DE Jr, Cercek B, Chambers CE, Chung MK, de Lemos JA, Diercks DB, Ellis SG, Fang JC, Franklin BA, Granger CB, Guyton RA, Hollenberg SM, Khot UN, Krumholz HM, Lange RA, Linderbaum JA, Mauri L, Mehran R, Morrow DA, Moussa ID, Mukherjee D, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Ting HH, 16 Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2015 focused update on primary PCI for patients with STEMI: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST- elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016;67(10):1235-1250.;.
Levine GN, O’Gara PT, Bates ER, Blankenship JC, Kushner FG, Ascheim DD, Bailey SR, Bittl JA, Brindis RG, Casey DE Jr, Cercek B, Chambers CE, Chung MK, de Lemos JA, Diercks DB, Ellis SG, Fang JC, Franklin BA, Granger CB, Guyton RA, Hollenberg SM, Khot UN, Krumholz HM, Lange RA, Linderbaum JA, Mauri L, Mehran R, Morrow DA, Moussa ID, Mukherjee D, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Ting HH, 16 Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2015 focused update on primary PCI for patients with STEMI: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST- elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016;133:1135-1147..;.
Levine GN, O’Gara PT, Bates ER, Blankenship JC, Kushner FG, Ascheim DD, Bailey SR, Bittl JA, Brindis RG, Casey DE Jr, Cercek B, Chambers CE, Chung MK, de Lemos JA, Diercks DB, Ellis SG, Fang JC, Franklin BA, Granger CB, Guyton RA, Hollenberg SM, Khot UN, Krumholz HM, Lange RA, Linderbaum JA, Mauri L, Mehran R, Morrow DA, Moussa ID, Mukherjee D, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Ting HH, 16 Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2015 focused update on primary PCI for patients with STEMI: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST- elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines. Catheter Cardiovasc Interv 2016;87:1001-19.;.
Bates E, Tamis-Holland JE, Bittl JA, O’Gara PT, Levine GN. PCI Strategies in Patients with ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: Review of the Evidence Base. J Am Coll Cardiol (in press) 2016.;.
Vloka ME, Tamis JE, Steinberg JS. Neurally Medicated Syncope in 2 Patients with Extracardiac Disease. Arch Intern Med Mar 22;159(6):625-7, 1999.;.
Halpern DG, Agarwal V Argulian E, Garcia W, Messerli F, Tamis-Holland JE. Beta Blockers for Blood Pressure Augmentation. J Hypertension 2013;31:422-23.;.
Argwal V, Chokshi N, Fovino LN, Thankachen J, Herzog E, and Tamis-Holland J¬. Extensive Coronary Disease in a 24 year Old Woman without Traditional Risk Factors Presenting as Cardiac Arrest. Women’s Health, Issues and Care 2014;3:1-2.;.
Tamis JE, and Steinberg JS. The Signal-Averaged Electrocardiogram: A Review of Methods and Clinical Applications. Annals of noninvasive Electrocardiology. 1:1-18, 1996..
Tamis JE, and Steinberg JS. Value of the Signal-Average P-Wave Analysis in Predicting Atrial Fibrillation after Cardiac Surgery. J of Electrocardial 30:36-43, 1998.
Tamis-Holland JE and O’Gara P. Highlights from the 2013 ACCF/AHA Guidelines for the Management of ST-Elevation Myocardial Infarction and Beyond. Clin Cardiol 2014:37(4):252-9..
Tamis-Holland JE, James JH. Con: Post-menopausal Hormone Replacement Therapy Improves Outcome in Women Undergoing Coronary Artery Bypass Graft Surgery. J Thorac and Cardio Anaesthesia 15:523-525, 2001 [editorial].;.
Hochman JS and Tamis-Holland JE. Acute Coronary Syndromes: Does Sex Matter? JAMA 2002;288: 3161-4. [editorial].;.
Tamis JE, and Hochman JS. Myocardial Infarction in Women. Wallis LA, ed. Textbook of Women’s Health. Lippincott-Raven Publishers, Philadelphia, PA 1998: 341-348.. In:.
Tamis JE, and Steinberg JS. The Impact of Atrial Fibrillation on Hospital Length of Stay after Cardiac Surgery. Steinberg JS, ed. Atrial Fibrillation After Cardiac Surgery. Kluwer Academic Publishers, Boston, MA 2000: 81-93.. In:.
Tamis-Holland, JE, Weinberg, C, Chiadika S, and Kim, B. Acute Coronary Syndromes in Women and the Elderly. Hong, M and Herzog E-ed. Acute Coronary Syndrome. Springer-Verlag London Ltd. 2007 . In:.
Tamis-Holland, JE, Joshi, S, and Palazzo, A. Diagnosis and Treatment of Non-ST-elevation Acute Coronary Syndromes. Hong, M and Herzog E-ed. Acute Coronary Syndrome. Springer-Verlag London Ltd. 2007 . In:.
Palazzo, A, Bangalore, S, Tamis-Holland, JE, and Chorzempa, A. Diagnosis and Treatment of Cardiogenic Shock. Hong, M and Herzog E-ed. Acute Coronary Syndrome. Springer-Verlag London Ltd. 2007 . In:.
Tamis-Holland JE and Chorzempa A. Non ST elevation myocardial infarction and unstable angina. Herzog-ed. The CCU Survival Guide. Lippincott, Williams and Wilkins 2012. In:.
Sbharwal MS, Rab ST, Tamis-Holland, JE. Unbundling Left Bundle Branch Block. Cardiosource: World News Interventions. August 2014.
Bates E, Tamis-Holland JE, Bittl JA, O’Gara PT, Levine GN. PCI Strategies in Patients with ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: Review of the Evidence Base. J Am Coll Cardiol 2016;68:1066–81.
Herzog E, Tamis-Holland, JE, Aziz E, Shapiro J. A Novel Program Focused on Women Survivors Who Were Enrolled in a Cardiac Arrest Pathway. Crit Pathways in Cardiol 2013;12: 28–30..;.
Tamis JE, and Steinberg JS. Atrial Fibrillation is the Only Modifiable Factor that Lengthens Hospital Stay after Coronary Artery Bypass Surgery. PACE 19:225, 1996. [abstract].
Hochman JS, Weaver DW, Tamis JE for the GUSTO IIB Investigators. The Effect of Gender on Clinical Presentation and Outcome for Patients with an Acute Coronary Syndrome: The GUSTO IIB Experience. Circulation 94:I-381, 1996. [abstract].
Tamis JE, Nichols K, Malhotra S, DePuey EG, Rozanski A. Comparison of Gated SPECT to X-ray Contrast Angiographic Ventricular Volume Measurements. J Am Coll Cardiol 29:482A, 1997. [abstract].
Tamis JE, Palazzo AM, Thompson T, and Hochman JS. Differential Rates of Diagnostic Testing for Men and Women with Acute Coronary Syndromes and their Effect on Outcome. Report from the GUSTO IIB Trial. Circulation 96-I-536, 1997. [abstract].
Hochman JS, Tamis JE, Stebbins AL, Boland G, and Ellis SG. Do Women with Acute MI Benefit More Than Men from Direct PTCA? Results of GUSTO IIB PTCA Substudy. Circulation 96:I-595,1997. [abstract].
Tamis JE, Vloka ME, Mindich BP, Malhotra S, and Steinberg JS. Atrial Fibrillation is Common After Minimally Invasive Direct Coronary Artery Bypass Surgery. J Am Coll Cardiol 31:118A, 1998. [abstract].
Menon V, Vemireddy M, Tamis JE, Thompson B, Knatterud GL, and Hochman JS, for the TIMI-3 Investigators. Impact of Smoking on Outcomes with Unstable Angina/non Q-wave MI: Report from the TIMI-3 registry. J Am Coll Cardiol 33:366A, 1999. [abstract].
Sutandar A, Tamis JE, Narula D, Gemayel CY, Vloka ME, and Steinberg JS. Atrial Fibrillation After Minimally Invasive Bypass Surgery is not Less Frequent than After CABG. PACE, 22:719,1999. [abstract].
Marinache SM,Leonard EF, Slater JN, Tamis JE, Popilskis SJ, Brunnert SR. Measurement of vascular compliance changes following stent implantation. Asaio J 1999:45 [abstract].
Sadanandan S, Tamis JE, Azadpour M, Chaipromprasit J, Aziz E, Homel P, and Slater, J. Clinical and Angiographic Predictors of CPK-MB Release Following Coronary Stent Implantation. J Am Coll Cardiol 35:4A, 2000. [abstract].
Tamis JE, Narula DD, Verma PB, Ehlert FA, Menshavez E and Steinberg JS. Are IV Beta-blockers Superior to Oral Beta-blockers in Preventing Atrial Fibrillation After Coronary Artery Bypass Surgery: Results of a Randomized Pilot Study. Ann Noninv Cardiol 5:S17, 2000. [abstract].
Tamis-Holland JE, Boden-Albala B, Feng Cheng J, Rundek T, Sacco RL. Sex Difference in the Presentation and Outcome of Stroke Patients. A Gender Analysis of the Northern Manhattan Stroke Study. Circulation 104; II-530, 2001. [abstract].
Bangalore, S, Ou, FS, Tamis-Holland, JE, Messerli, F, Roe, M, Peterson E. Relationship Between Heart Rate and Blood Pressure with In Hospital Mortality in Patient Presenting with Unstable Angina/ NSTEMI: A CRUSADE analysis. Circulation 2006. [abstract].
Jorapur, V, Sadowski, Z, Reynolds, HR, Carvalho, AC, Buller, C, Rankin, J Renkin, J, Steg, PG, White, H, Vozzi, C, Balcells, E, Ragosta, M,, Martin, CE, Tamis-Holland, JE, Srinivas, V, Wharton, W, Abramsky, S Mon, AS, Barton, B, Lamas, GA and Hochman, JS. Chronic kidney disease, ejection fraction and heart failure in patients with occluded infarct-related arteries post-myocardial infarction: data from the Occluded Artery Trial. Circulation 2006;114:II_400 [abstract].
Tamis-Holland, JE, Lu, J, Lopes, N, Bittner, V, Jacobs, AJ, Magee, M and the BARI 2D Investigators. Sex, Prescribing practices and guideline recommended treatment goals at baseline in the BARI 2D study. J Am Coll Card 49;193A, 2007 [abstract].
Aziz, E, Tamis-Holland, JE, Bangalore, Musat, D, Platsman, Z, Tormey, D, Fawzy, A, Leung, G, Herzog, E, Coven, D and Hong, M. Role of Renal Function in Vascular Access Complications Rates in Patiens Undergoing Percutaneous Coronary Procedures Using Arteriotomy Closure Devices. J Am Coll Cardiol 2007;49(Supplement B); 6B [abstract].
Tamis-Holland, JE, Lu, J, Bittner, V, Magee, MF, Delaney, J, Kip, KE, Schwartz, LE, Lopes, N, Jacobs AK, for the BARI 2D Investigators. Sex, Clinical Symptoms and Angiographic Findings at Baseline in BARI 2D. Circulation 2007 ;116:II_638-II_639. [abstract].
Aziz, EF, Florita, C, Bangalore, S, Pulimi, S, Bangalore, S, Musat, D, Rhee, HK, Hana, MA, Tormey, D, Lee,S, Herzog, E, Coven, D, Syed, T, Tamis-Holland, J, Hong, MK. Antibiotic Prophylaxis in Diabetic Patients Undergoing Cardiac Catheterization and Treated with Closure Devices Dramatically Decreases Infection Risk. J Am Coll Cardiol 51 (Supplement B);B95, 2008 [abstract].
Tamis-Holland, JE, Chen, A, Roe, M, Hochman, J, Palazzo, A, Chorzempa, A, Peterson, E. Sex, Age and Outcome Among Non-ST segment Elevation Acute Coronary syndromes.J Am Coll Cardiol 51 (Supplement);A378, 2008 [abstract].
Mirant-Borde, MC, Weathers, LW, Koneru, J, Chug, L, Rivera, PJ, Daza, R, Tamis-Holland, JE. Low rate of heart disease awareness in an Urban Community; A call for more aggressive outreach. J Am Coll Cardiol 51(Supplement);A361, 2008. [abstract].
Reynolds, HR, Tamis-Holland JE, Kronsberg SS, Steg PG, Carvalho AC, Loboz-Grudzien K, Kruk M, Sopko G, Ruzyllo W, Pearte CA, Forman, SA, Lamas G, Hochman, JS. Sex Differences in Outcomes after Myocardial Infarction with Persistent Total Occlusion of the Infarct Artery: Analysis of the Occluded Artery Trial. Circulation 2008;118:S967. [abstract].
Eslava, D.; Mirant-Borde, M.C.; Upegui, J; Tamis-Holland, J. An Evaluation of Women’s Perceived Risk for Coronary Artery Disease: Perception is not Always Reality. Circ Cardiovasc Qual Outcomes. 2009;2:e1-e66. [abstract].
Serrano-Gomez CS, Yang Y, Tamis-Holland JE, Coven D, Palazzo A, Leber R, Simon C, Chorzempa A, Hong MK Peri-Procedural Administration of Glycopyrrolate Prevents Angiojet Thrombectomy-Associated Bradyarrhythmias in STEMI Patients. CCI 2009 [abstract].
Chorzempa A, Bangalore S, Daka M, Janis G, Smith IQ, Coven D, Palazzo A, Leber R, Tamis-Holland J, Hong MK. A Novel Risk Score to Predict Triple Vessel Disease in Patients with Acute ST-Segment Elevation Myocardial Infarction. CCI 2009 [abstract].
Tamis-Holland, JE, Lu, J, Korytkowski, M, Rogers, WJ, Lopes, N, Magee, M, Mighton, L, Jacobs, AL for the BARI 2D Investigators. Lack of Sex-Based Differences in Outcomes in Patients with Type 2 Diabetes and Coronary Artery Disease Treated With Contemporary Medical Therapy With or Without Prompt Revascularization: A Report From BARI 2D. J Am Coll Cardiol 2010;55;A128.E1198 [abstract].
Serrano C, Yan YK, Kang H, Cianci, C, LeMonda B, Hong MK, Coven DC, PalazzoA, Simon C, Leber R, Chorzempa A, Tamis-Holland JE. Sex and ACT following Heparin Bolus During Percutaneous Coronary Intervention. J Am Coll Cardiol 2010;55;A206.E1938 [abstract].
Eslava DJ, Mirant-Borde MC, Upegui J, Romero J, Alviar CL, Cordova JP, and Tamis-Holland JE. Incidence, Perception, and Knowledge of Obesity in Minority Women. Abstract Presented at the American Heart Association’s 50th Cardiovascular Disease Epidemiology and Prevention and Nutrition, Physical Activity and Metabolism - 2010 Joint conference. americanheart.org [abstract].
Cordova JP, Korniyenko A, Alviar CL, Nadkarni GN, Eslava DJ, Romero JE, Chorzempa A, Fridman V, Cianci C, Kearney K, Kantrowitz N, Hong M, Fox J, and Tamis-Holland JE. Atypical Symptoms are Associated with Delays to Hospital Presentation and Prolonged Door to Balloon Times in Patients with ST Elevation Myocardial Infarction. Circulation 2010;122:A21158 [abstract].
Eslava, DJ, Cordova JP, Korniyenko A, Nadkarni GN, Alviar CL, Romero JE, Chorzempa A, Fridman V, Wysoczanski M, Cianci C, Kearney K, Kantrowitz N, Fox H. Hong M., Tamis-Holland, JE. Lack of English Comprehension is Associated with Delays in Hospital Presentation in Patients with Acute Myocardial Infarction. American Heart Association Quality of Care and Outcomes Research 2011. americanheart.org [abstract].
Cordova JP, Korniyenko A, Nadkarni GN, Eslava DJ, Romero J, Chorzempa A, Fridman V, Alviar CL, Wysoczanski M, Cianci C, Kearney K, Hong M, Kantrowitz N, Fox J, and Tamis –Holland JE. Cardiac Symptoms and Time to Presentation in Women and Men with ST-Segment Elevation Myocardial Infarction. American Heart Association Quality of Care and Outcomes Research 2011. americanheart.org [abstract].
Chorzempa A, Soma, V, Kamath G, Lizardo I, Tamis-Holland J, Coven D, Palazzo A, Leber R, Simon C, Hong MK. Equivalent ACT Response to Bivalirudin between Elective and ACS Patients. CCI 2011:77:S118. [abstract].
Krone RJ, Althouse AV, Venkitachalam L, Forker, Fuentes F, Pena-Sing I, Tamis-Holland J, Ocampo S, Campos A, Mori Brook M. Predictors of Revascularization in the Cohort Assigned to Only Initial Medical Treatment in the BARI 2D Trial Circulation 2011 [abstract].
Bader,E, Benjo A, Tabaksblat M, Chorzempa A, Pamidimukata CK, Aziz E, Gurzoy E, Pierce W, Mirza T, and Tamis-Holland JE. Decreased in-hospital mortality in hypertensive patients undergoing STEMI: Is hypertension to be encouraged? J Am Coll Cardiol. 2013;61(10S) [abstract].
Chorzempa A, Hong M, Coven D, Leber R, Simon C, Tamis-Holland J, and Palazzo A. Platelet Inhibition and Gender Difference after Loading Aspirin and Thienopyridine in Percutaneous Coronary Intervention (PIGLET-PCI) Study CCI 2013 [abstract].
El-Hayek GE, Benjo A, Aziz E, Pierce W, and Tamis Holland JE. Pre-treatment with high dose statin decreases acute cardiovascular events in unstable patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled studies. J Am Coll Cardiol 2013;62:18-S1 [abstract].
El-Hayek GE, Herzog E, Hong MK, Benjo A, Tamis-Holland JE. Prolonged Dual Antiplatelet Therapy Following Drug Eluting Stent Implantation: More Bleeding and No Reduction in Ischemic Events-A Meta-Analysis of Clinical Trials J Am Coll Cardiol 2014;63(12_S):. doi:10.1016/S0735-1097(14)60097-8 [abstract].
Chatterjee S, El-Hayek GE, Tamis-Holland JE. And Herzog E. Competing Risk of Major Adverse Cardiovascular Events and Major Bleeds in the era of New Anti-platelet Therapy: A Meta-analysis of Randomized Trials J Am Coll Cardiol 2014;63(12_S):. doi:10.1016/S0735-1097(14)60106-6 [abstract].
Bavishi C, Sawant A, Ather S, Tamis-Holland JE. Safety and Efficacy of Triple versus Dual Anti-platelet Therapy After Stent Implantation in Patients Requiring Chronic Anticoagulation: A Meta-analysis of Observational Studies. Circulation 2014;130:A18102 [abstract].
Bavishi C, Patel D, Chatterjee S, Trivedi V, Tamis-Holland JE. Short and Long Term Mortality in Women and Men Undergoing Primary Angioplasty: A Comprehensive Meta-analysis. Circulation 2014;A18048 [abstract].
Ashar AE, Sabharwal MP, Dominguez AAC, Maleki ND, Tamis-Holland, JE, El-Hayek G, Palazzo A. Troponin Testing in the Emergency Setting: Analysis of Appropriateness Circ Cardiovasc Qual Outcomes. 2015;8:A279 [abstract].
Granieri MJ, Koulova A, Cordova JP, Agarwal V, Trignano S, Tamis-Holland JE. Knowledge of Heart Disease in Female and Male College Students. Circ Cardiovasc Qual Outcomes. 2015; 8: A271 [abstract].
Gongora C, Casso Dominguez A, Bavishi C, Pena J, Chavez P, Arora Shilpkumar, Moreno P, Tamis-Holland J. Clinical Outcomes of Patients Treated With First Generation Vs. New Generation Drug-Eluting Stents for Left Main Coronary Artery Disease. Circulation. 2015;132:A17806 [abstract].
Correa A, Casso Dominguez A, Tamis-Holland JE. Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients with Acute Coronary Syndrome: A Meta-analysis of >40,000 patients. J Am Coll Cardiol 2016;67(13_S):37 [abstract].
Bavishi C, Trivedi V, Chatterjee S, Tamis-Holland, JE. Efficacy and Safety of Low to medium-dose versus High-dose Aspirin after Percutaneous Coronary Intervention: Evidence beyond CURRENT-OASIS 7 trial. J Am Coll Cardiol. 2016; 67(13_S):203 [abstract].
Bavishi C, Panwar S, Pirrotta S, Baber U, Dangas G, Moreno P, Tamis-Holland J, Kini A, and Sharma S . Efficacy and Safety of First Generation versus Newer Generation Drug-El;uting Stents in Patients with Diabetes: A Direction Comparison Meta-analysis of 8,438 Patients from Randomized Trials. J Am Coll Cardiol. 2016; 67(13_S):290 [abstract].
Hinohara TT, Fordyce C, Sherwood M, Gu J, Al-Khalidi H, Roettig M, Berger P, Corbett C, Tamis-Holland J, Burchenal J, Monk L, Hadley Wilson B, Jollis J, Christopher Granger. Impact of Regional Systems of Care on Disparities of Care in Females and Blacks Presenting with ST Elevation Myocardial Infarction. J Am Coll Cardiol. 2016; 67(13_S):630 [abstract].
Bates ER, Tamis-Holland JE, Bittl J, O’Gara PT, Levine GN. PCI Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease. J Am Coll Cardiol. 2016; 68(10):1066-1081 [abstract].
Gupta A, Yeh RW, Tamis-Holland JE, Patel SH, Guyton RA, Klein LW, Rab T, KirtaneAJ. Implications of Public Reporting of Risk-Adjusted Mortality following PCI: Misperceptions and Potential Consequences for High-Risk Patients including the Non-Surgical Patient. JACC Cardiovasc Interv 2016;9: 2077–85.;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Tamis-Holland did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.